Walgreens Partners to Expand Colorectal Cancer Screening Access
The initiative gives eligible pharmacy customers a streamlined pathway to request the Cologuard stool DNA test, with no prep or special diet required.
Read MorePosted by CLP Edit Staff | Mar 13, 2026 | Colorectal |
The initiative gives eligible pharmacy customers a streamlined pathway to request the Cologuard stool DNA test, with no prep or special diet required.
Read MorePosted by CLP Edit Staff | Mar 12, 2026 | Molecular Diagnostics |
Baylor Genetics has added optical genome mapping and long-read sequencing to its whole genome sequencing test, expanding STR analysis, enabling FMR1 methylation detection, and improving structural variant interpretation.
Read MorePosted by CLP Edit Staff | Mar 12, 2026 | Molecular Diagnostics |
The Menlo Park-based company is integrating epigenetic signatures into its rare disease diagnostics offering, with the new capability set to roll out automatically in early Q2 2026.
Read MorePosted by CLP Edit Staff | Mar 11, 2026 | Colorectal |
Physicians can now order the Shield blood test through Quest’s network of nearly 650,000 clinician and hospital accounts, patient service centers, and in-office phlebotomists.
Read MorePosted by CLP Edit Staff | Mar 10, 2026 | Kidney Disease |
Insight Molecular Diagnostics has completed clinical validation and received ISO 13485 certification for its GraftAssureDx kidney transplant rejection test kit, moving toward FDA submission, according to the company.
Read More